PGY-2 Critical Care Pharmacy Residency Program
PGY2 residency programs build upon Doctor of Pharmacy (PharmD) education
and PGY1 pharmacy residency training to develop pharmacist practitioners
with knowledge, skills, and abilities as defined in the educational competency
areas, goals, and objectives for advanced practice areas. Residents who
successfully complete PGY2 residency programs are prepared for advanced
patient care or other specialized positions, and board certification in
the advanced practice area, if available.
Swedish Medical Center’s ASHP-accredited PGY2 Critical Care Pharmacy
Residency Program has been training the next generation of critical care
pharmacy leaders since 2020. Our mission is to create an environment for
residents to master critical care pharmacotherapy, develop their own progressive
practice, and lead the profession forward through innovation, education,
and collaboration. We want our residents to feel both challenged and supported
as they take ownership of their growth and aspirations. Training at a
community health system within Washington State affords our residents
the opportunity to practice autonomously at the top of their license as
an essential stakeholder within the healthcare team. We currently offer
1 PGY2 critical care pharmacy resident position.
Requirements for Successful Program Completion
- Obtain a Washington State pharmacist license within the first 90 days of
the program
- Maintain Advanced Cardiac Life Support (ACLS) Pediatric Advanced Life Support
(PALS), and Neonatal Resuscitation Program (NRP) certifications for the
duration of the program
- Complete all required rotation learning experiences: Orientation, Surgical
Intensive Care, Neuro Critical Care, Cardiac Intensive Care, Neonatal
and Pediatric Intensive Care, Medical Intensive Care, and Emergency Medicine
- Complete 2 elective rotation learning experiences
- Complete all required longitudinal learning experiences: Longitudinal Research
Project, Medication Use Evaluation, Drug Class Review, and Staffing
- Active participation in all assigned committees: Residency Advisory Committee,
Residency Interview Committee, Critical Care Council, and Pulmonary Embolism
Response Team Committee
- Reach Achieved for Residency for at least 80% of objectives with no objectives
marked as Needs Improvement
- Complete all required presentations: American Society of Health-System
Pharmacists (ASHP) Midyear Clinical Meeting longitudinal research project
poster presentation, Western States Conference longitudinal research project
presentation, and a Continuing Pharmacy Education presentation
- Complete manuscript for longitudinal research project suitable for publication
in a critical care- or pharmacy-focused journal
- Complete all required documentation: initial assessment and quarterly development
plans, learning experience and preceptor evaluations, duty hour attestations,
and the required disease states spreadsheet
Application Process
We sincerely welcome all applicants who meet the criteria below, regardless
of race, ethnicity, disability, gender identity or expression, sexual
orientation, socioeconomic status, religion, or age. Please note that
we are unable to sponsor Green Cards or Visas at this time.
- Graduation from an ACPE-accredited pharmacy school
- Completion of an ASHP-accredited PGY1 residency program (or program undergoing
accreditation process)
- Ability to work in the United States
- Eligibility for Washington State pharmacist licensure
-
Submission of application in PhORCAS by December 31st at 2100 PST, including
- Curriculum vitae
- One-page letter of intent addressed to the Residency Interview Committee
- Three letters of recommendation.
